Ilika still has plenty to offer investors even though the share price is up 100% year-to-date, according to analysts at Liberum.
First deliveries of its Stereax miniature solid-state batteries to Blink Energy, CubeWorks and Lura Health suggest commercialisation of its medical SSBs is gaining momentum.
“Ongoing discussions with Cirtec remain encouraging and we would not be surprised to see a positive near-term outcome.
At Goliath, the company is targeting Li-ion energy density parity by the end of 2023 ahead of implementing a scale-up to mega-factory scale in order to support a commercial roll-out of a small portfolio of electric hyper and supercar models.”
A share price of 46.5p offers "material value" to investors reckons the broker, which has a "buy" rating and 60p target (up from 59p) on the shares.